Sponsor or institution

Clinical trials and research at Anhui Provincial Hospital

• 46Clinical trials
• 1New in 30 days
• 1Country

Newest trials

All recruiting trials (46)

• Tislelizumab with Tofacitinib and Docetaxel for NSCLC After First-Line Immunotherapy

  This study tests whether adding tofacitinib to tislelizumab and docetaxel helps people with locally advanced or metastatic NSCLC who did not respond to first-line immunotherapy.

  Recruiting Phase 2 Anhui Provincial Hospital · Hefei, Anhui · NCT07925866

• Multimodal Survival Predictor for Colorectal Liver Metastases After Surgery

  Researchers are testing a tool that combines MRI-derived tumor features with clinical data to predict survival after surgery for colorectal liver metastases.

  Recruiting Anhui Provincial Hospital · Hefei, Anhui · NCT07830576

• Zinc add-on with targeted therapy plus immunotherapy for advanced liver cancer

  This study tests whether adding daily zinc to standard targeted therapy and immunotherapy helps people with unresectable or advanced hepatocellular carcinoma.

  Recruiting Phase 2 Anhui Provincial Hospital · Hefei, Anhui · NCT07793695

• Reconstruction kinetics of γδ T cells after an unrelated cord blood transplant

  This study tests how γδ T cells recover after an unrelated cord blood transplant and whether recovery patterns relate to outcomes like graft-versus-host disease, relapse, and survival.

  Recruiting Anhui Provincial Hospital · Hefei, Anhui · NCT07782684

• Liver Volume Metrics to Predict Immunotherapy Outcomes in Unresectable HCC

  This multicenter study tests whether baseline functional liver volume and total liver volume can forecast how patients with unresectable HCC respond to immunotherapy and how long they survive.

  Recruiting Anhui Provincial Hospital · Hefei, Anhui · NCT07782632

• Metastatic liver cancer patient registry from multiple Chinese centers

  This is a registry that collects real-world data on adults with liver metastases to understand patterns and prognosis and to support future research.

  Recruiting at 2 sites Anhui Provincial Hospital · Bengbu, Anhui and 2 other locations · NCT07602504

• How long to take sulfamethoxazole after a kidney transplant

  This study will test whether different lengths of sulfamethoxazole (TMP‑SMX) taken after a kidney transplant better prevent Pneumocystis jirovecii pneumonia in adult transplant recipients.

  Recruiting Anhui Provincial Hospital · Hefei, Anhui · NCT07231770

• Anti-CD19 gene therapy for B-cell lymphoma

  This trial will try an Anti-CD19 gene injection in adults with relapsed or refractory B-cell lymphoma to see if it is safe and can shrink tumors.

  Recruiting Anhui Provincial Hospital · Hefei, Anhui · NCT07211048

• Intravenous umbilical cord blood cell infusion alongside standard Alzheimer's medication

  This trial will try giving an IV infusion of umbilical cord blood mononuclear cells to people aged 50–75 with mild to moderate Alzheimer's alongside their usual medications to see if it helps symptoms or biological disease markers.

  Recruiting Early Phase 1 Anhui Provincial Hospital · Hefei, Anhui · NCT07208344

• Ivonescimab with short-course hypofractionated radiotherapy for second-line esophageal squamous cell carcinoma

  This will try Ivonescimab plus a short course of higher‑dose radiotherapy as a second‑line option for adults (18–80) with locally advanced or metastatic esophageal squamous cell carcinoma who have failed first‑line therapy.

  Recruiting Phase 2 Anhui Provincial Hospital · Hefei, Anhui · NCT07188103

• Using polyene phosphatidylcholine to protect the liver after hepatectomy

  This test checks whether giving polyene phosphatidylcholine before surgery plus magnesium isoglycyrrhizinate after surgery better prevents liver injury in people having laparoscopic liver resection for hepatocellular carcinoma.

  Recruiting Phase 4 Anhui Provincial Hospital · Hefei, Anhui · NCT07150624

• One-time anti-CD19/BCMA CAR gene therapy for refractory autoimmune diseases

  This study will try a one-time intravenous anti-CD19/BCMA CAR gene therapy to see if it helps adults whose autoimmune disease has not responded to standard treatments.

  Recruiting Anhui Provincial Hospital · Hefei, Anhui · NCT07121777

• Metabolically armed tumor‑infiltrating lymphocytes (Meta10‑TIL) therapy for advanced solid tumors

  This study will try giving Meta10‑TIL, specially prepared immune cells, to adults with advanced solid tumors to see if it's safe and can help control tumor growth.

  Recruiting Early Phase 1 Anhui Provincial Hospital · Hefei, Anhui · NCT07106814

• AI to diagnose and predict outcomes of lung nodules using smartphone photos

  This will test whether an AI model can use smartphone photos of removed lung nodules to diagnose the pathology and predict prognosis for adults undergoing surgery for lung nodules.

  Recruiting at 3 sites Anhui Provincial Hospital · Hefei, Anhui and 2 other locations · NCT07098884

• Telpegfilgrastim to prevent neutropenia in people with solid tumors

  This project will test whether telpegfilgrastim injections can prevent chemotherapy-related low neutrophil counts in adults with solid tumors who are at increased risk.

  Recruiting at 2 sites Anhui Provincial Hospital · Hefei, Anhui and 1 other locations · NCT07096479

• Metabolically armed BCMA CAR-T (Meta10-BCMA) for relapsed or refractory plasma cell neoplasms

  This treatment tries a metabolically modified BCMA-targeted CAR-T cell therapy for adults with relapsed or refractory multiple myeloma, plasma cell leukemia, or AL amyloidosis who have had at least three prior therapies.

  Recruiting Early Phase 1 Anhui Provincial Hospital · Hefei, Anhui · NCT07085559

• BCMA- and CD19-directed CAR-T therapy for refractory autoimmune diseases

  This treatment will try BCMA- and CD19-targeted CAR-T cells in adults whose autoimmune disease hasn't responded to standard therapies.

  Recruiting Anhui Provincial Hospital · Hefei · NCT07052565

• Timing of umbilical cord blood infusion and risk of acute graft-versus-host disease after transplant

  This trial will test whether giving a single-unit unrelated umbilical cord blood transplant at different times of day changes the chance of acute graft-versus-host disease in people with malignant blood disorders who are in remission.

  Recruiting Phase 3 Anhui Provincial Hospital · Hefei, Anhui · NCT07047456

• Gene therapy for patients with relapsed immune thrombocytopenia

  This study is testing a one-time gene therapy injection to see if it can help people with relapsed immune thrombocytopenia who haven't had success with other treatments.

  Recruiting Anhui Provincial Hospital · Changsha, Hunan · NCT06973356

• Using patients' own modified immune cells to treat certain blood cancers

  This study is testing a new treatment using modified immune cells to see if it can help people with certain blood cancers like multiple myeloma, leukemia, and lymphoma.

  Recruiting Anhui Provincial Hospital · Hefei · NCT06961669

• Romiplostim N01 for leukemia-related CTIT in adults

  This study tests whether Romiplostim N01 can help adults with leukemia who have low platelets caused by cancer treatment.

  Recruiting Phase 2 Anhui Provincial Hospital · Hefei, Anhui · NCT06898983

• Registry of liver cancer patients in China

  This study is creating a detailed database of liver cancer patients in China to help improve treatment and research for different types of liver cancer.

  Recruiting at 38 sites Anhui Provincial Hospital · Anqing, Anhui and 37 other locations · NCT06777485

• Comparing two PET imaging agents for prostate cancer diagnosis

  This study is testing a new PET imaging agent for prostate cancer to see if it works better than an existing one in diagnosing the disease and spotting any spread or recurrence.

  Recruiting Early Phase 1 Anhui Provincial Hospital · Hefei, Anhui · NCT06756334

• Evaluating the diagnostic value of MRI in prostate cancer detection

  This study is testing if certain MRI measurements can help doctors better detect prostate cancer in patients who are suspected of having it.

  Recruiting Anhui Provincial Hospital · Hefei, Anhui and 1 other locations · NCT06737588

• Using Romiplostim N01 to help platelet recovery after umbilical cord blood transplantation

  This study is testing if a medication called Romiplostim N01 can help adults recover their platelet levels faster after receiving umbilical cord blood transplants.

  Recruiting Phase 2 Anhui Provincial Hospital · Hefei, Anhui · NCT06693791

• Using lusutrombopag and thrombopoietin to treat low platelet counts in liver disease patients before surgery

  This study is testing if a combination of two medications can help increase low platelet counts in adults with liver disease before they have surgery, to reduce the need for blood transfusions.

  Recruiting at 2 sites Phase 2 Anhui Provincial Hospital · Fuyang, Anhui and 1 other locations · NCT06673498

• Treatment for high-risk recurrent intrahepatic cholangiocarcinoma using Tislelizumab and S-1

  This study is testing if a combination of the immunotherapy drug Tislelizumab and the chemotherapy drug S-1 can help people with high-risk recurrent intrahepatic cholangiocarcinoma feel better after surgery.

  Recruiting at 2 sites Phase 2 Anhui Provincial Hospital · Fuyang, Anhui and 1 other locations · NCT06664021

• New method for early detection of epithelial ovarian cancer using blood samples

  This study is testing a new blood test to see if it can help detect ovarian cancer earlier by looking for specific signals in the blood of patients and healthy people.

  Recruiting Anhui Provincial Hospital · Hefei, Anhui · NCT06640348

• Comparing 5.0T and 3.0T MRI for diagnosing prostate cancer

  This study is testing whether a stronger 5.0T MRI can find prostate cancer more accurately than the standard 3.0T MRI in men who are being checked for the disease.

  Recruiting Anhui Provincial Hospital · Hefei, Anhui · NCT06612047

• Neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy for esophageal cancer

  This study tests a new treatment plan that combines chemotherapy and immunotherapy before surgery, followed by more therapy after surgery, to see if it helps people with advanced esophageal cancer.

  Recruiting Anhui Provincial Hospital · Hefei · NCT06602843

• Evaluating Coenzyme I for Hematopoietic Recovery After Cord Blood Transplantation

  This study is testing if a new injection called coenzyme I can help people recover better after receiving a cord blood transplant for blood cancers.

  Recruiting Phase 1 Anhui Provincial Hospital · Hefei, Anhui · NCT06558253

• Neoadjuvant AK104 with chemotherapy before surgery in advanced ovarian cancer

  This study tests a combination of AK104 with chemotherapy before surgery to see if it helps patients with advanced ovarian cancer who are at high surgical risk.

  Recruiting Phase 3 Anhui Provincial Hospital · Hefei, Anhui · NCT06542549

• Combining hypofractionated radiotherapy with immunotherapy for limited-stage small-cell lung cancer

  This study is testing if a shorter radiation treatment combined with a new immunotherapy can help people with limited-stage small-cell lung cancer live longer without their cancer getting worse.

  Recruiting Phase 1/2 Anhui Provincial Hospital · Hefei, Anhui · NCT06527898

• Combining Donafenib and Envafolimab for Patients at High Risk of Liver Cancer Recurrence

  This study is testing if a new combination of two drugs, donafenib and envafolimab, can help prevent liver cancer from coming back in patients who have just had surgery for it and are at high risk for recurrence.

  Recruiting at 2 sites Phase 2 Anhui Provincial Hospital · Fuyang, Anhui and 1 other locations · NCT06498622

• Local treatment for liver metastases in colorectal cancer patients

  This study tests if combining local treatment for liver tumors with regular cancer therapy can help people with colorectal cancer live longer and feel better.

  Recruiting at 6 sites Anhui Provincial Hospital · Chuzhou, Anhui and 5 other locations · NCT06449937

• Combining short-course radiotherapy with Raltitrexed and Tislelizumab for advanced esophageal cancer

  This study is testing a new treatment that combines short radiation therapy with two medications to see if it helps people with advanced esophageal cancer that has come back or gotten worse.

  Recruiting Anhui Provincial Hospital · Hefei · NCT06408584

• Classifying individuals at risk for cervical cancer

  This study is trying to find out if certain genetic markers can help identify people at risk for cervical cancer by analyzing their blood samples and following them for five years.

  Recruiting Anhui Provincial Hospital · Hefei, Anhui · NCT06405945

• Treatment to reduce anti-HLA antibodies before stem cell transplantation

  This study is testing a new treatment to lower harmful antibodies in patients with high levels before they receive a stem cell transplant, to see if it helps them have fewer complications and better outcomes.

  Recruiting Phase 2 Anhui Provincial Hospital · Hefei, Anhui · NCT06362967

• Evaluating iMesenchymal Stromal Cells for Steroid-Refractory Acute Graft-versus-Host Disease

  This study is testing if a new type of stem cell treatment can help people with acute graft-versus-host disease who haven't responded to steroids.

  Recruiting Anhui Provincial Hospital · Hefei, Anhui · NCT06321198

• Injecting RD06-03 CART cells to treat relapsed or refractory B-lymphoblastic leukemia

  This study is testing whether RD06-03 CART cell injections can safely help people with relapsed or hard-to-treat B-lymphoblastic leukemia.

  Recruiting at 2 sites Early Phase 1 Anhui Provincial Hospital · Hefei, Anhui and 1 other locations · NCT06307600

• Timing the donor stem cell infusion to reduce acute graft-versus-host disease after donor blood stem cell transplant

  This trial tests whether changing the clock time when donor peripheral blood stem cells are given can lower the risk and severity of acute graft-versus-host disease in people aged 12–60 having their first allogeneic peripheral blood stem cell transplant for nonmalignant blood disorders.

  Recruiting at 6 sites Phase 3 Anhui Provincial Hospital · Hefei, Anhui and 5 other locations · NCT06294691

• Combining low-dose radiation with immune therapy for recurrent cervical cancer

  This study is testing if a combination of low-dose radiation and an immune therapy drug can help patients with recurrent cervical cancer who can't have chemotherapy.

  Recruiting Phase 1 Anhui Provincial Hospital · Hefei, British Columbia · NCT06232083

• Monitoring menopausal symptoms in women with gynecological cancer after ovary removal

  This study looks at how menopause symptoms and bone health change over time in women aged 18-55 with gynecological cancer who have had their ovaries removed, to find the best ways to help them feel better and prevent bone loss.

  Recruiting Anhui Provincial Hospital · Hefei, Anhui · NCT06151028

• Combining postoperative radiotherapy and immunotherapy for advanced esophageal cancer

  This study is testing if combining radiation therapy with immunotherapy after surgery can help people with advanced esophageal cancer live longer and have fewer side effects.

  Recruiting Phase 1/2 Anhui Provincial Hospital · Hefei, Anhui · NCT05937438

• Combining immunonutrition with chemoradiotherapy for inoperable esophageal cancer

  This study is testing whether a special nutritional formula can help people with inoperable esophageal cancer live longer and feel better when combined with chemoradiotherapy.

  Recruiting Anhui Provincial Hospital · Hefei · NCT05833594

• Using Avatrombopag to Help Platelet Recovery After Cord Blood Transplantation

  This study is testing if a medication called Avatrombopag can help people with bone marrow failure recover their platelet levels after receiving a cord blood transplant.

  Recruiting Anhui Provincial Hospital · Hefei, Anhui · NCT05823376

Quick answers

How many clinical trials run by Anhui Provincial Hospital are recruiting right now?

46, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 9, Early Phase 1: 5, Phase 3: 3, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →